IXHL
Incannex HealthcareยทNASDAQ
--
--(--)
--
--(--)
IXHL Profile
Incannex Healthcare Inc.
A company that develops combinations of synthetic cannabinoids and psychedelic agents
Suite 105, 8 Century Circuit Norwest, NSW 2153, Australia
--
Incorporated in Delaware in July 2023, Incannex Healthcare Inc., is a clinical-stage biopharmaceutical company focused on the development of innovative medicines for patients with severe chronic diseases and unmet medical needs. The company's product line includes drug candidates for diseases such as obstructive sleep apnea, generalized anxiety disorder and inflammatory diseases, making it a developer of innovative treatments in the biopharmaceutical industry.
